Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 October 1993 | Volume 119 Issue 8 | Pages 828-835
The field of cardiac pacing has expanded rapidly in recent years. Engineering improvements and microprocessor technology have resulted in a vast increase in pacemaker technology. The "high-tech" edge of cardiac pacing often discourages all but the pacemaker specialist from approaching a malfunctioning pacemaker. Electrocardiographic signs of pacemaker malfunction can be grouped into four categories: failure to output, failure to capture, undersensing, and inappropriate pacemaker rate. For each of these categories, there may be true malfunctions and pseudomalfunctions. In addition, environmental sources of electromagnetic interference, both within and outside the hospital environment, can result in pacemaker malfunction. Approaching pacemaker malfunction with these categories in mind should help minimize confusion.
Author and Article Information
From the Mayo Clinic and Mayo Foundation, Rochester, Minnesota; the Watson Clinic, Lakeland, Florida.
REVIEW
Pacemaker Malfunction
![]()
Requests for Reprints: David L. Hayes, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
This article has been cited by other articles:
![]() |
D. Lakkireddy, A. Khasnis, J. Antenacci, K. Ryshcon, M. K. Chung, D. Wallick, W. Kowalewski, D. Patel, H. Mlcochova, A. Kondur, et al. Do electrical stun guns (TASER-X26(R)) affect the functional integrity of implantable pacemakers and defibrillators? Europace, July 1, 2007; 9(7): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nazarian, A. Roguin, M. M. Zviman, A. C. Lardo, T. L. Dickfeld, H. Calkins, R. G. Weiss, R. D. Berger, D. A. Bluemke, and H. R. Halperin Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla Circulation, September 19, 2006; 114(12): 1277 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luechinger, V. A. Zeijlemaker, E. M. Pedersen, P. Mortensen, E. Falk, F. Duru, R. Candinas, and P. Boesiger In vivo heating of pacemaker leads during magnetic resonance imaging Eur. Heart J., February 2, 2005; 26(4): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Martin, J. A. Coman, F. G. Shellock, C. C. Pulling, R. Fair, and K. Jenkins Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1315 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Duru, R Luechinger, M.B Scheidegger, T.F Luscher, P Boesiger, and R Candinas Pacing in magnetic resonance imaging environment: Clinical and technical considerations on compatibility Eur. Heart J., January 2, 2001; 22(2): 113 - 124. [PDF] |
||||
![]() |
C. D. Collard and S. C. Body Anesthetic Implications for Patients With Permanent Pacemakers Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 144 - 151. [Abstract] [PDF] |
||||